23.4.05

Schwinn Sting-Ray - Press Release - Electric Sting-Ray Launch

Schwinn Sting-Ray - Press Release - Electric Sting-Ray Launch: "MADISON, Wis. - April 2005 - How do you improve the fastest selling bicycle of all time? Schwinn's wildly popular 2004 Sting-Ray bicycle is getting a charge - literally - via an electric motor. In May 2005, Schwinn will launch the first electric version of the Sting-Ray.

'Sales to-date of our Schwinn Sting-Ray 'Street Series ' have been phenomenal,' said Pacific Cycle Inc.'s Founder and CEO, Chris Hornung. Pacific Cycle owns the Schwinn Bicycles brand. 'Consumers can't seem to get enough of this bike, and we've begun producing new models to complement the original, such as a three-speed version and various shapes, sizes and color schemes. This newest, electric model is one we're very excited about. We think it's going to be a huge success, and it opens the door of opportunity to new power assisted transportation, which we feel will be very popular in the near future.'

The new Sting-Ray Electric will be available at various Schwinn retailers beginning in late May 2005 at an MSRP of $399. It shares the original design characteristics of the Street Series Sting-Ray, but adds an electric motor and a battery pack in the form of a motorcycle engine casing. The Sting-Ray Electric will reach speeds up to 14 mph and a fully charged battery will last up to two hours."

Yahoo! News - L.A. Doctor to Get $1.35B in Settlement

Yahoo! News - L.A. Doctor to Get $1.35B in Settlement: "LOS ANGELES - Orthopedic surgeon Gary Michelson said Friday he is considering philanthropic alternatives for some of the $1.35 billion Medtronic Inc. plans to pay him to end a patent dispute."

22.4.05

Wired News: Cave Pharming Yields Big Crops

Wired News: Cave Pharming Yields Big Crops: "It's not the bucolic, sun-dappled landscape you might envision when picturing American farmland. But a chilly, damp cave with no natural light just may be the most productive agricultural environment around.

Purdue researchers and entrepreneur Doug Ausenbaugh didn't launch an underground farm because they thought it would yield more crops. They wanted to provide biotech companies a safe environment for growing crops containing pharmaceutical drugs for humans. But they were pleasantly surprised to find that not only did the former quarry apparently keep pollen from the corn, tobacco, soybeans, tomatoes and potatoes from escaping, but it also led to higher yields than greenhouses or outdoor fields."

Email destroys the mind faster than marijuana - study | The Register

Email destroys the mind faster than marijuana - study | The Register: "Modern technology depletes human cognitive abilities more rapidly than drugs, according to a psychiatric study conducted at King's College, London. And the curse of 'messaging' is to blame.

Email users suffered a 10 per cent drop in IQ scores, more than twice the fall recorded by marijuana users, in a clinical trial of over a thousand participants. Doziness, lethargy and an inability to focus are classic characteristics of a spliffhead, but email users exhibited these particular symptoms to a 'startling' degree, according to Dr Glenn Wilson.

The deterioration in mental capacity was the direct result of the trialists' addiction to technology, researchers discovered."

New Scientist Breaking News - Stink bomb gas puts mice into suspended animation

New Scientist Breaking News - Stink bomb gas puts mice into suspended animation: "Suspended animation has been deliberately induced in a species of mouse which does not naturally hibernate. It is the first time such a feat has been achieved, say the procedure’s pioneers.

If a similar response could be triggered in humans, there would be major healthcare benefits and the futuristic idea of putting astronauts into suspended animation on long-haul space flights could move a step closer to reality.

The mice were induced to fall into their deep sleep after being exposed to hydrogen sulphide - the gas which gives rotten eggs and stink bombs their characteristic foul odour. The animals later revived in ordinary air."

20.4.05

CNN.com - Some see Virgin Mary in underpass stain - Apr 20, 2005

CNN.com - Some see Virgin Mary in underpass stain - Apr 20, 2005: "CHICAGO, Illinois (AP) -- A steady stream of the faithful and the curious, many carrying flowers and candles, have flocked to an expressway underpass for a view of a yellow and white stain on a concrete wall that some believe is an image of the Virgin Mary."

The Sun Newspaper Online - UK's biggest selling newspaper

The Sun Newspaper Online - UK's biggest selling newspaper: "A THOUSAND Star Wars fans will watch all six films back-to-back — ending with the premiere of new episode Revenge Of The Sith."

Will a new gold coin make a mint? - Apr. 19, 2005

Will a new gold coin make a mint? - Apr. 19, 2005: "On Tuesday, officials in Washington announced the planned introduction of the first 24-karat gold coin in the nation's history. The piece, set to be rolled out sometime in 2006, will boast a 99.99 percent 'fineness' rating. In other words, it's almost perfectly pure gold.

When the Mint releases a coin into general circulation, such as the recently introduced five-cent piece, the purpose is simply to provide a medium for transactions -- a few nickels to rub together, as it were.

The new gold coins are different. They won't enter into general circulation, but will be sold instead to investors and collectors.

The purpose of rolling them out, the Mint is making clear, is to make money -- perhaps a lot of it."

19.4.05

Liquid Medical Marijuana Approved in Canada

Liquid Medical Marijuana Approved in Canada: "OTTAWA, CANADA -- The Canadian government today announced final approval of a natural marijuana extract, sold under the brand name Sativex, as a prescription drug. The action marks the first time a natural marijuana product has been approved for prescription sale anywhere in the Western Hemisphere since marijuana prohibition was instituted in the last century.

Sativex -- a liquid that is sprayed into the mouth -- has been initially approved for treatment of neuropathic pain in multiple sclerosis patients."